News & Updates

In the secondary analysis of the phase III ADVANCE trial, responder rates were markedly higher with atogepant irrespective of dose than with placebo in adults with migraine.

The risk of developing dementia in older adults appears to be elevated in the presence of atrial fibrillation, with some indication of a risk increase already at age <65 years, according to a study.

Patients with multiple sclerosis can benefit from a 6-week regimen of whole-body vibration, which can improve their fine motor accuracy, functional mobility, and quality of life, reports a recent study.

Individuals with resistant hypertension who undergo lifestyle modification have better cognitive function, and this benefit may be attributed to the reduced ambulatory systolic blood pressure (SBP) changes through weight loss, suggests a study.

An investigational digital intervention delivered through a video game–based interface, called AKL-T03, significantly improves attention span and cognitive functioning among patients with major depression when compared to a control condition, a study has shown. In addition, it is well tolerated and has minimal adverse events.

In the treatment of patients with drug-resistant focal epilepsy, transdermally administered cannabidiol is well tolerated but is not superior to placebo in terms of reducing seizure frequency, according to a study.

Selective serotonin reuptake inhibitors (SSRIs) can prevent and treat depression following stroke, in addition to improving anxiety, dependence, motor function, and cognitive function—benefits that are only reproducible with citalopram but not fluoxetine, according to a meta-analysis said to be the most up to date.

The connectivity strength of the ventral striatum (VS) within the reward network demonstrates links to depressive disorders and anhedonia from mid to late adolescence, which indicates the role played by this circuitry in depression changes with age, reveals a study.